Athenex, Inc. IPO Research Information

Athenex, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Athenex, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Athenex, Inc.	ATNX - NASDAQ	$11.00-$13.00	$11.00	$12.00	6 million	6/14/2017
Underwriter(s): Credit Suisse, Deutsche Bank Securities, J.P. Morgan
Co-Manager(s): ICBC International
Industry: Health Care
Filing(s): Filed 2017-05-12 Terms Added 2017-06-02

Athenex, Inc. Quote & Chart - Click for current quote - ATNX

About Athenex, Inc. (adapted from Athenex, Inc. prospectus):
They are a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "ATNX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.